AstraZeneca has expanded its use of Elixir Software’s R&D workflow-management software, with a three-year contract, in part to support communication while it is moving offices in the United Kingdom from Alderley Park to Cambridge.
This agreement will allow AstraZeneca to apply Elixir’s cloud-based software to other scientific areas. Elixir singled out the facilitation of scientific communication during AstraZeneca’s relocation to Cambridge as a major benefit of expanding the relationship.
Elixir and AstraZeneca began working together two years ago. Since then Elixir’s work-scheduling software iTraX has become an established tool to connect internal teams and CROs involved with R&D at AstraZeneca
“iTraX has become an integral part of our [drug metabolism and pharmacokinetic] workflow,” Dr. Matt Wood, associate director of oncology DMPK at AstraZeneca, said in a statement. “The system has saved a significant amount of [full-time equivalent] time and allowed us to apply the lean process thinking of visual planning to our diverse working environment.”
This is about the fourth IT contract AstraZeneca is known to have entered into since January.
Source: Fierce Biotech IT